Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical and Vaccine Immunology : CVI|March 6, 2015
Seroprevalence of Antibody-Mediated, Complement-Dependent Opsonophagocytic Activity against Neisseria meningitidis Serogroup B in EnglandHolly E Humphries, Charlotte Brookes, Lauren Allen, et al.
Journal of Immunological Methods|March 15, 2013
Development of a large scale human complement source for use in bacterial immunoassaysCharlotte Brookes, Eeva Kuisma, Frances Alexander, et al.
IJID Regions|June 20, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in a population living in Bomassa village, Republic of CongoLine Lobaloba Ingoba, Jean Claude Djontu, Claujens Chastel Mfoutou Mapanguy, et al.
One Health Outlook|May 24, 2021
Development and validation of portable, field-deployable Ebola virus point-of-encounter diagnostic assay for wildlife surveillanceDania M Figueroa, Eeva Kuisma, M Jeremiah Matson, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 13, 2019
Long-term wildlife mortality surveillance in northern Congo: a model for the detection of Ebola virus disease epizooticsEeva Kuisma, Sarah H Olson, Kenneth N Cameron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2015
Dilemmas in Managing Pregnant Women With Ebola: 2 Case ReportsSéverine Caluwaerts, Tessy Fautsch, Daphne Lagrou, et al.
Plos Neglected Tropical Diseases|June 22, 2022
Zaire ebolavirus surveillance near the Bikoro region of the Democratic Republic of the Congo during the 2018 outbreak reveals presence of seropositive batsStephanie N Seifert, Robert J Fischer, Eeva Kuisma, et al.
The Lancet. Global Health|December 14, 2016
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling studyDaouda Sissoko, Sophie Duraffour, Romy Kerber, et al.
Pageof 2